Should you buy IDEXX Laboratories (IDXX)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
IDXX currently trades below the base anchor, in the lower half of the engine methodology range.
Engine methodology range — mechanically derived from pipeline gate outputs + peer-multiple inputs. Not an analyst price target. JSON-LD emission gated pending counsel review.
What the engine is tracking
- Wide Moat Best In Class Quality→Stable
- Expensive Valuation Thin Upside↑Improving
- Perfect Four Quarter Beat Streak→Stable
- +1 more pillar — see the Why tab for full reasoning
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Wide Moat Best In Class Quality
Trip ifGross margin falls below 20% for 2 consecutive quarters, indicating pricing power is structurally eroding from the current 25% level.
- P2Perfect Four Quarter Beat Streak
Trip ifEPS falls below consensus by more than 2% in 2 of the next 3 reported quarters.
- P3Expensive Valuation Thin Upside
Trip ifForward P/E multiple compresses below 25x for 2 consecutive quarters, resolving the expensive-valuation concern.
- P4Confirmed Price Downtrend
Trip ifPrice rises above $655 (more than 15% above current $570) and holds for 3 consecutive weeks, confirming the downtrend has reversed.
How the engine reached this verdict
TrendMatrix's engine output for IDEXX Laboratories, Inc. (IDXX) is STRONG_BUY_WAIT with medium conviction, score 5.8/10 at $513.39. The engine flags WAIT: the structural case holds but the entry-asymmetry math improves at lower prices.
The engine's suggested entry zone is $509.56, currently 0.8% above entry. Target $608.06, stop $485.84, asymmetric R:R 3.69. The WAIT designation reflects entry-discipline framing — chasing into the current zone compresses asymmetry, which is why the engine separates WAIT from NOW. The engine's sizing output: 1.0% of portfolio at this asymmetry level (high-conviction tier).
On the bull side: V7 flight-to-quality bonus: +0.5 (Q=8.4 in RISK_OFF); Sector modifier (Healthcare): +0.5; Strong earnings beat streak (4/4). On the bear side: Concentration risk — Supplier: Ortho-Clinical Diagnostics; Below 200-MA, MA slope -4.0%/30d (confirmed downtrend).
BUY_NOW requires asymmetry R:R climbing above the 2.5 conviction threshold (currently 3.69); the verdict flips to HOLD if overall score deteriorates by ~0.7.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates IDXX — 10-dimension breakdown →
Bull case
- ▸V7 flight-to-quality bonus: +0.5 (Q=8.4 in RISK_OFF)
- ▸Sector modifier (Healthcare): +0.5
- ▸Strong earnings beat streak (4/4)
Bear case
- ▸Concentration risk — Supplier: Ortho-Clinical Diagnostics
- ▸Below 200-MA, MA slope -4.0%/30d (confirmed downtrend)